{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-21-020786","form_type":"8-K","ticker":"BCPC","cik":"0000009326","company_name":"BALCHEM CORP","filed_at":"2021-10-29T23:59:59+00:00","discovered_at":"2026-05-14T18:04:16.318164+00:00","generated_at":"2026-06-28T16:27:36.043751+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Balchem reports record Q3 2021 sales of $197.9M, net earnings $25.0M, EPS $0.77","bullets":["Net sales $197.9M, up 13% YoY; record sales in all three segments: Human Nutrition, Animal Nutrition, and Specialty Products.","GAAP EPS $0.77; adjusted EPS $0.92 vs $0.83 prior year; adjusted EBITDA $48.3M, up 9%.","Cash flow from operations $39.6M, free cash flow $31.1M, both up YoY.","Started new Metalosate production line in Marano, Italy to serve international customers.","Completed ERP consolidation to Microsoft Dynamics 365 on budget and on time."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-21-020786","json":"https://secwatch.observer/filing/0001628280-21-020786.json","markdown":"https://secwatch.observer/filing/0001628280-21-020786.md","text":"https://secwatch.observer/filing/0001628280-21-020786.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/9326/000162828021020786/0001628280-21-020786-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/9326/000162828021020786/bcpc-20211029.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T16:27:36.043751+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}